Normal view MARC view ISBD view

The JAK-STAT pathway: a therapeutic target in hematological malignancies.

Ferrajoli, A

The JAK-STAT pathway: a therapeutic target in hematological malignancies. [electronic resource] - Current cancer drug targets Dec 2006 - 671-9 p. digital

Publication Type: Journal Article; Review

ISSN: 1873-5576

Standard No.: 10.2174/156800906779010227 doi

Subjects--Topical Terms:
Animals
Antibodies, Monoclonal--therapeutic use
Hematologic Neoplasms--drug therapy
Histone Deacetylase Inhibitors
Humans
Janus Kinases--antagonists & inhibitors
PPAR gamma--agonists
Protein-Tyrosine Kinases--antagonists & inhibitors
STAT Transcription Factors--antagonists & inhibitors
Signal Transduction--drug effects

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)